Gulbe, Amie Jane L.
HRN: 21-93-43 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/21/2022
CO-AMOXICLAV 625MG (TAB)
09/21/2022
09/28/2022
PO
625mg
Q12
Uti
Waiting Final Action